As of June 2026, 1 paid clinical trial is recruiting for Melanoma in Houma, Louisiana. Melanoma trials test immune checkpoint inhibitors, adoptive cell therapies, and BRAF/MEK targeted combinations in both early and metastatic disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Houma has approximately 40 recruiting research studies across a wide range of therapeutic areas. Louisiana hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Researchers run research studies in Houma, LA at 16 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cardiovascular Institute of the South | Heart Failure, Peripheral Artery Disease, Tricuspid Valve Disease | 18 |
| Terrebonne General Medical Center | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Anatomic Stage I Breast Cancer AJCC v8 | 6 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| CIS Clinical Research | Iliofemoral; Thrombosis, Thrombosis, Deep Vein | 2 |
| Tandem Clinical Research | Crohn's Disease, Inflammatory Bowel Diseases, Metabolic Dysfunction-associated Steatohepatitis | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| CIS Clinical Research Corporation | Peripheral Vascular Diseases | 1 |
| Cardiovascular Institute South | Cardiovascular Diseases, Functional Mitral Regurgitation, Heart Diseases | 1 |
| Cardiovascular Institute of the South - Houma | Peripheral Arterial Disease | 1 |
| Dr. Falk Investigational Site | Eosinophilic Esophagitis | 1 |
| Oncology Center of The South Incorporated | Previously Treated Non-Small Cell Lung Cancer | 1 |
| Tandem Clinical Research GI - Houma | Chronic Idiopathic Constipation (CIC) | 1 |
| Tandem Intermediate, LLC - Houma -Site Number: 8400034 | Ulcerative Colitis | 1 |
| Tandem Intermediate, LLC - Houma-Site Number: 8400034 | Crohn's Disease | 1 |
| Teche Action Clinic - Houma | Obesity | 1 |
| Terrebone - Cardiovascular Institute of the South | Atrial Fibrillation, Stroke | 1 |
Recruiting trials in Houma grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Louisiana are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Louisiana research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Houma from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 40 recruiting clinical trials in Houma, Louisiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Houma compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Houma include Heart Failure (7), Cardiovascular Diseases (2), Crohn's Disease (2), Heart Valve Diseases (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Houma on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Houma include Cardiovascular Institute of the South, Terrebonne General Medical Center, Akero Clinical Study Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Houma are Cardiovascular (13), Cancer & tumors (6), Diabetes & metabolic (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.